Search
Close this search box.
Logo Asphalion
Resources Hub

xEVMPD management | ASPHALION SERVICE “MINI PILL”

xEVMPD management is the Extended Eudravigilance Medicinal Product Dictionary of the European Medicinal Agency (EMA), which defines controlled vocabulary to be used for the marketing authorisation of medicinal products.

xEVMPD management is the Extended Eudravigilance Medicinal Product Dictionary of the European Medicinal Agency (EMA), which defines controlled vocabulary to be used for the marketing authorisation of medicinal products.
December 12, 2022
| , ,

The submission of data on medicines by marketing authorisation holders is a legal requirement from Article 57(2) of Regulation (EC) No. 726/2004, as amended by Regulation (EU) 1235/2010 and Regulation (EU) 1027/2012.

At Asphalion we have a dedicated team, fully trained and greatly experienced in supporting the activities related to xEVMPD. Proactively, we provide pre-filled templates that ease providing the required information for the creation and maintenance of data. We offer a quick and efficient solution that allows you to be compliant and on time.

Check out our #serviceminipill to see how ASPHALION can help you with the xEVMPD management!!

You can check out all pharmaceutical data management services here: DATA MANAGEMENT

For further information, please contact us at: info@asphalion.com

Search News & Events

  • Search

  • Filter by category

Share

Related news and events

NEWS | EMA to launch paediatric submissions on IRIS platform

April 24, 2024

The launch will bring several benefits, such as enabling quicker interaction between applicants and EMA, and improving data quality through integration with other EMA systems. Furthermore, the IRIS platform will allow applicants to monitor the status of their paediatric applications from any device and receive automatic updates on the status of their submissions. These features will significantly enhance the transparency and efficiency of the paediatric application process.  

Introducing AsphaSearch

April 23, 2024

As a company, at Asphalion, we constantly endeavor to lead in embracing the latest trends. In this spirit, we wholeheartedly dedicate ourselves to integrating digital tools that streamline our processes, enhance our efficiency, and enable us to deliver unparalleled quality to all our clients.

EVENT | 20th Biosimilar Medicines Conference by MFE

April 12, 2024

During these two interactive days, actors of the healthcare community alongside world experts in biosimilar medicines will gather and debate the evolving biosimilar medicines landscape and emerging trends. Discussion will focus on sharing good practices and setting collective aims to achieve the depth, breadth and speed of the use of biosimilar medicines as a lever to untap their transformative value.

More news & Events

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Logo Asphalion
Free Meeting

Services

Follow us!

Memberships & Partnerships

Catalonia Trade & Investment - ACCIÓ
Team PRRC
Veeva Certified Partner

Quality Management System

© Asphalion

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule Now!
Schedule a meeting